The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis - AcademicCME

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis

1.0

Claim your AMA PRA Category 1 Credit or CNE Contact Hour

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

The New Era of Biologic Therapies to Treat Patients with COPD: Best Practices for the Pulm...

The New Era of Biologic Therapies to Treat Patients with COPD: Best Practices for the Pulm...

Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease...